CLINICAL_TRIALS ClinicalTrials.gov record update

A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate (120 μg and 240 μg) and 2 Different Daily Doses of Minirin® Tablet (0.2 mg and 2 x 0.2 mg) in Children and Adolescents With Primary Nocturnal Enuresis (PNE)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00209261
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:10.871054+00:00
Published At: 2011-05-19T00:00:00+00:00
Record Updated At: 2011-05-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Primary Nocturnal Enuresis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2011-05-19"
protocolSection.identificationModule.nctId: "NCT00209261"
protocolSection.identificationModule.officialTitle: "A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin\u00ae Oral Lyophilisate (120 \u03bcg and 240 \u03bcg) and 2 Different Daily Doses of Minirin\u00ae Tablet (0.2 mg and 2 x 0.2 mg) in Children and Adolescents With Primary Nocturnal Enuresis (PNE)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.